| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―17 |
Heart damage in patients with coronavirus infection |
M.V. Chistyakova, A.V. Govorin, V.A. Kalinkina, Y.V. Kudryavtseva |
| 2 |
[GO] |
2025―Dec―15 |
Features of the course of a new coronavirus infection in patients with bronchoobstructive pathology |
V.A. Uliatovskii, V.Yu. Filippov, D.V. Cherkashin, I.S. Salakhbekov, E.V. Chepiga, D.S. Bogdanov, et al. (+2) A.V. Chumakov, A.N. Nikashin |
| 3 |
[GO] |
2025―May―14 |
Prolactin level in patients hospitalized with COVID-19 |
S.M. Voevoda, O.D. Rymar, A.A. Radionova, L.V. Shcherbakova, V.O. Borisova, T.N. Karpenko, A.Ya. Velichko |
| 4 |
[GO] |
2024―Sep―30 |
Prediction of fatal outcome in hospital patients with COVID-19 and comorbid pathology |
N.Yu. Borovkova, L.Yu. Eliseeva, A.S. Tokareva, P.S. Zubeev, G.N. Zubeeva |
| 5 |
[GO] |
2024―May―31 |
Pathomorphological features of the myocardia in patients with COVID-19 |
D.S. Evdokimov, S.A. Boldueva, E.D. Resnyanskaya, S.A. Vinnichuk |
| 6 |
[GO] |
2024―May―31 |
Genetic predictors of survival and development of MACE in the acute COVID-19 in patients with high cardiovascular risk |
M.S. Tyuryupov, K.S. Shulenin, T.S. Svyoklina, G.G. Kutelev, D.K. Shulenin, A.E. Alanichev, D.V. Cherkashin |
|
